Participation in a randomized phase III study (evaluating the role of adjuvant docetaxel in high-risk breast cancer patients) improves treatment strategies and individual patient care in recruiting centers: The ADEBAR-Trial.

被引：0
|
作者：
Janni, W
Sommer, H
Rack, B
Steinfeld, D
Augustin, D
Heinrigs, M
Gauger, K
Kiechle, M
Harbeck, N
Friese, K
机构：
[1] Univ Munich, Frauenklin, Munich, Germany
[2] Zentralklinikum, Frauenklin, Augsburg, Germany
[3] Mammazentrum Ostbayer, Deggendorf, Germany
[4] Tech Univ Munich, Frauenklin, D-8000 Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75S / 75S
页数：1
相关论文
共 50 条
  • [1] Participation in phase III ADEBAR: Evaluating the role of adjuvant docetaxel in high-risk breast cancer patients improves treatment strategies and individual patient care in recruiting centers
    von Bismarck, F.
    Janni, W.
    Rack, B.
    Thieleke, W.
    Strobl, B.
    Steinfeld, D.
    Augustin, D.
    Sommer, H.
    Kiechle, M.
    Harbeck, N.
    EJC SUPPLEMENTS, 2004, 2 (03): : 71 - 71
  • [2] Participation in phase III ADEBAR: evaluating the role of adjuvant docetaxel in high-risk breast cancer patients improves treatment strategies and individual patient care in recruiting centers.
    Gauger, K
    Janni, W
    von Bismarck, F
    Rack, B
    Strobl, B
    Steinfeld, D
    Augustin, D
    Simon, W
    de Waal, J
    Schindlbeck, C
    Sommer, H
    Kiechle, M
    Harbeck, N
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S94 - S94
  • [3] The ADEBAR-trial: Effect of participation in a randomized phase III study (evaluating the role of adjuvant docetaxel in high-risk breast cancer patients) on treatment strategies and individual patient care in recruiting centers
    Sommer, H
    Janni, WJ
    Rack, B
    Steinfeld, D
    Simon, W
    Augustin, D
    Heinrigs, M
    Bismarck, FV
    Harbeck, N
    Kiechle, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 24S - 24S
  • [4] ADEBAR study, a phase III study on the assessment of the role of docetaxel in the adjuvant treatment of patients with high-risk nodal-positive breast cancer: conclusive toxicity data
    Annecke, K.
    Janni, W.
    Rack, B.
    Augustin, D.
    Harbeck, N.
    Kiechle-Bahat, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 517 - 517
  • [5] Phase III study evaluating the role of docetaxel in the adjuvant setting of breast cancer patients with ≥4 involved lymph nodes:: ADEBAR-Study.
    Gauger, K
    Bismarck, FV
    Heinrigs, M
    Janni, W
    Steinfeld, D
    Augustin, D
    Sommer, H
    Friese, K
    Kiechle, M
    Harbeck, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 104S - 104S
  • [6] The ADEBAR trial: Final toxicity analysis of a phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement
    Janni, J. W.
    Sommer, H.
    Rack, B.
    Augustin, D.
    Simon, W.
    Steinfeld, D.
    Annecke, K.
    Harbeck, N.
    Friese, K.
    Kiechle-Bahat, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Final toxicity analysis of the adebar phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement
    Janni, W.
    Harbeck, N.
    Sommer, H.
    Rack, B.
    Augustin, D.
    Simon, W.
    Wischnik, A.
    Annecke, K.
    Friese, K.
    Kiechle, M.
    ONKOLOGIE, 2008, 31 : 46 - 46
  • [8] Final toxicity analysis of the ADEBAR phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement
    Janni, W.
    Harbeck, N.
    Sommer, H.
    Rack, B.
    Augustin, D.
    Simon, W.
    Jueckstock, J.
    Wischnik, A.
    Annecke, K.
    Friese, K.
    Kiechle-Bahat, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S149 - S149
  • [9] Phase III study evaluating the role of Docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement (*4 LK+) - Current State of the ADEBAR Study
    不详
    BREAST, 2005, 14 : S36 - S36
  • [10] THE SUCCESS-TRIAL - TOXICITY ANALYSIS OF A PHASE III STUDY EVALUATING THE ROLE OF DOCETAXEL AND GEMCITABINE IN THE ADJUVANT THERAPY OF BREAST CANCER PATIENTS
    Genss, E.
    Sommer, H.
    Sehouli, J.
    Lichtenegger, W.
    Schneider, A.
    Beckmann, M. W.
    Friese, K.
    ANTICANCER RESEARCH, 2009, 29 (05) : 1566 - 1566
12345